Method of treating inflammatory disease with cardamonin
This invention relates to a method of treating inflammatory disease characterized by the production of an undesirable level on inflammatory mediators such as nitric oxide, thromboxane B₂ , prostaglandin E₂, or hydrogen peroxide. The method comprising of administering to a patient a pharmacologycal e...
Saved in:
Main Authors: | , , , |
---|---|
Format: | Patent |
Published: |
2011
|
Online Access: | http://psasir.upm.edu.my/id/eprint/20457/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | This invention relates to a method of treating inflammatory disease characterized by the production of an undesirable level on inflammatory mediators such as nitric oxide, thromboxane B₂ , prostaglandin E₂, or hydrogen peroxide. The method comprising of administering to a patient a pharmacologycal effective dose of cardamonin with a pharmaceutically acceptable carrier. The effective dose of cardamonin with a rage between about 0.02uM and 74 uM.
|
---|